Sarah L Trice

Title: The Innovative Contributions of Sarah L Trice

Introduction

Sarah L Trice is a notable inventor based in Glenside, Pennsylvania. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target HIV. Her work is crucial in the ongoing fight against HIV and AIDS, showcasing her dedication to improving public health.

Latest Patents

Sarah L Trice holds a patent for HIV integrase inhibitors. The compounds of Formula I are designed to inhibit HIV integrase and, consequently, HIV replication. These compounds are useful for the prophylaxis or treatment of HIV infection and the delay in the onset or progression of AIDS. They can be utilized as compounds per se or in the form of pharmaceutically acceptable salts. Additionally, these compounds may be included in pharmaceutical compositions, potentially in combination with other antivirals, immunomodulators, antibiotics, or vaccines. The patent also describes processes for making these compounds and their intermediates.

Career Highlights

Sarah L Trice is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. Her role in the company has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout her career, Sarah has collaborated with esteemed colleagues such as Richard C A Isaacs and Wayne J Thompson. These collaborations have further enhanced her research and innovation in the field.

Conclusion

Sarah L Trice's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions to HIV research are vital in the ongoing battle against this global health issue.